Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Kidney Disease (End-Stage Renal Disease or ESRD) - Drugs In Development, 2022, provides an overview of the End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) (Genito Urinary System And Sex Hormones) pipeline landscape. End-stage kidney ... Read More
-
Fanconi Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Fanconi Anemia (Hematological Disorders) pipeline landscape. Fanconi anemia (fan-KO-nee uh-NEE-me-uh), or FA, is a rare, inherited blood disorder that leads to bone marrow failure. The disorder also is called Fanconi’s ... Read More
-
Migraine Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Migraine (Central Nervous System) pipeline landscape. Migraine is a disorder characterized by repeated attacks of severe headache. A migraine headache causes throbbing or pulsating pain, usually on only one side of the ... Read More
-
Aplastic Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Aplastic Anemia (Hematological Disorders) pipeline landscape. Aplastic anemia is a syndrome of bone marrow failure characterized by peripheral pancytopenia and marrow hypoplasia. Symptoms include fatigue, pale skin, rapid or irregular ... Read More
-
Hypothyroidism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Hypothyroidism (Hormonal Disorders) pipeline landscape. Hypothyroidism (underactive thyroid) is a condition in which thyroid gland doesn't produce enough of certain important hormones. Signs and symptom include fatigue, constipation, dry skin, puffy face, ... Read More
-
Hypereosinophilic Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Hypereosinophilic Syndrome (Hematological Disorders) pipeline landscape. The hypereosinophilic syndrome (HES) is a disease characterized by a persistently elevated eosinophil count (≥ 1500 eosinophils/mm³) in the blood for at least six ... Read More
-
Anaphylaxis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Anaphylaxis (Immunology) pipeline landscape. Anaphylaxis is a severe, potentially life-threatening allergic reaction. Anaphylaxis symptoms include dizziness, nausea, vomiting or diarrhea, feeling of warmth, constriction of the airways and a swollen tongue or ... Read More
-
Amyotrophic Lateral Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Amyotrophic Lateral Sclerosis (Central Nervous System) pipeline landscape. Amyotrophic lateral sclerosis (ALS) is the most common degenerative disease of the motor neuron system. The disorder is named for ... Read More
-
Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Infections - Drugs In Development, 2022, provides an overview of the Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections (Infectious Disease) pipeline landscape. Methicillin-Susceptible Staphylococcus aureus (MSSA) is a bacterium that is resistant to many antibiotics. MSSA usually ... Read More
-
Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Glycogen synthase kinase 3 beta also known as GSK3B is an enzyme encoded by the GSK3B. It constitutively activate ... Read More
-
Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Kinase C Epsilon Type - Drugs In Development, 2022'; Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) pipeline Target constitutes close to 11 molecules. Out of which approximately 11 molecules are ... Read More
-
Global Undifferentiated Pleomorphic Sarcoma Therapeutics Market - 2022-2029
... at a CAGR of XX % during the forecast period (2022-2029). Soft tissue cancers include malignant fibrous histiocytoma, often undifferentiated pleomorphic sarcoma. It's rare cancer that frequently metastasizes to other body regions and returns after ... Read More
-
Global Artificial Intelligence (AI) in Healthcare Market Size study, by Offering (Hardware, software, Services) by Technology (Machine learning, Natural Language Processing, Context-aware Computing, Computer Vision), by Application (Patient Data & Risk Analysis, Inpatient Care & Hospital Management, Medical Imaging & Diagnostics, Lifestyle Management & Monitoring, Virtual Assistants, Drug Discovery, Research, Healthcare Assistant Robots, Precision Medicine, Emergency Room & Surgery, Wearables, Mental Health, Cybersecurity), By End User (Hospital & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers, Others) and Regional Forecasts 2022-2028
... Hospital Management, Medical Imaging & Diagnostics, Lifestyle Management & Monitoring, Virtual Assistants, Drug Discovery, Research, Healthcare Assistant Robots, Precision Medicine, Emergency Room & Surgery, Wearables, Mental Health, Cybersecurity), By End User (Hospital & Healthcare Providers, ... Read More
-
Global Spectrometry Market Size study, by Type (Molecular Spectrometry, Mass Spectrometry (MS), Atomic Spectrometry) by Product (Instrument, Consumables, Services) by Application (Proteomics, Metabolomics, Pharmaceutical Analysis, Forensic Analysis, Others) by End-use (Government & Academic Institutions, Pharmaceutical & Biotechnology Companies, Others) and Regional Forecasts 2022-2028
... & Biotechnology Companies, Others) and Regional Forecasts 2022-2028 Global Spectrometry Market is valued approximately USD 15.12 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.20 % over ... Read More
-
Global Ceftiofur Market - 2022-2029
... the forecast period (2022-2029). Ceftiofur is a veterinary drug that has been licensed to treat a variety of ailments in pigs, beef or dairy cattle, and other animals. It is a third-generation cephalosporin antibiotic that ... Read More
-
Crohn’s Disease Therapeutics Market Forecast - Epidemiology & Pipeline Analysis
... (IBD) that causes digestive tract inflammation, leading to abdominal pain, severe diarrhea, fatigue, weight loss, and malnutrition. The inflammatory bowel disease treatment market can be segmented into two types, i.e., Crohn's Disease and Ulcerative Colitis. ... Read More
-
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Resistant, Androgen-Independent) Prostate Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer ... Read More
-
Systemic Sclerosis (Scleroderma) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Systemic Sclerosis (Scleroderma) Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Autism Spectrum Disorder Epidemiology Analysis and Forecast, 2021-2031
... individuals have difficulty communicating with others, have restricted interests, display repetitive behaviors, and struggle to function in a normal working environment. As symptoms generally manifest in the first two years of life, the condition is ... Read More
-
Hypertriglyceridemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Hypertriglyceridemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Hypertriglyceridemia. Report includes ... Read More
-
Osteoarthritis Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021 - 2031
... cause of disability and pain among the elderly in the western world. It is a slowly progressive joint disease characterized by degradation of the articular (hyaline) cartilage that coats the bone proximities of synovial joints. ... Read More
-
Leishmaniasis (Kala-Azar) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Leishmaniasis (Kala-Azar) Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
2022 Neoplasms (Tumors) (C00-D49) Global Market Size & Growth Report with Updated Forecasts
... forecasts for 2022 and 2026. The historical data utilizes in-depth survey results from companies that sell neoplasms (tumors) (c00-d49) combined with country and regional economic, firmographic, and demographic data. Our analysts develop the forecasts using ... Read More
-
Rare Diseases Treatment Market - Global Industry Analysis (2019 - 2021), Growth Trends, and Market Forecast (2022 - 2029)
... 2022 to 2029. Orphan drug development has emerged as the foremost growth enabler across the market, setting the stage for innovation-driven expansion. World over, the incidence of rare diseases and genetic disorders has been increasing, ... Read More
-
2022 Endocrine, Nutritional and Metabolic Diseases, and Immunity Disorders (E00-E89) Global Market Size & Growth Report with Updated Forecasts
... are from 2012 through 2021, with forecasts for 2022 and 2026. The historical data utilizes in-depth survey results from companies that sell endocrine, nutritional and metabolic diseases, and immunity disorders (e00-e89) combined with country and ... Read More
Research Assistance
